IRIS UniCatt

Paris, Ida
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.411
AS - Asia 2.024
EU - Europa 1.302
SA - Sud America 391
AF - Africa 62
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 4
Totale 6.200
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.319
SG - Singapore 902
CN - Cina 369
BR - Brasile 319
IT - Italia 305
VN - Vietnam 295
SE - Svezia 252
DE - Germania 189
FR - Francia 154
IN - India 115
GB - Regno Unito 82
FI - Finlandia 75
HK - Hong Kong 68
IE - Irlanda 66
BD - Bangladesh 52
ID - Indonesia 51
CA - Canada 42
JP - Giappone 38
RU - Federazione Russa 32
MX - Messico 31
AR - Argentina 30
PH - Filippine 22
ZA - Sudafrica 22
PL - Polonia 21
ES - Italia 20
NL - Olanda 20
TR - Turchia 19
KR - Corea 18
AT - Austria 16
BE - Belgio 15
PK - Pakistan 14
UA - Ucraina 14
CI - Costa d'Avorio 13
IQ - Iraq 13
CO - Colombia 11
EC - Ecuador 9
IR - Iran 9
VE - Venezuela 9
MA - Marocco 7
JO - Giordania 6
UZ - Uzbekistan 6
CL - Cile 5
HU - Ungheria 5
JM - Giamaica 5
KE - Kenya 5
KZ - Kazakistan 5
RO - Romania 5
TN - Tunisia 5
BZ - Belize 4
CH - Svizzera 4
CR - Costa Rica 4
CZ - Repubblica Ceca 4
EU - Europa 4
AU - Australia 3
AZ - Azerbaigian 3
BG - Bulgaria 3
EG - Egitto 3
LT - Lituania 3
MY - Malesia 3
NP - Nepal 3
PE - Perù 3
SA - Arabia Saudita 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AL - Albania 2
CG - Congo 2
ET - Etiopia 2
HN - Honduras 2
IL - Israele 2
MD - Moldavia 2
NO - Norvegia 2
PT - Portogallo 2
PY - Paraguay 2
RS - Serbia 2
TH - Thailandia 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
GD - Grenada 1
HR - Croazia 1
IM - Isola di Man 1
IS - Islanda 1
KG - Kirghizistan 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
SC - Seychelles 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
Totale 6.200
Salva come PNG Salva come JPEG
Città #
Singapore 567
Chandler 278
San Jose 263
Ashburn 235
Ho Chi Minh City 87
New York 85
Council Bluffs 81
Beijing 76
Hanoi 74
Los Angeles 72
Hyderabad 66
Rome 66
Dublin 64
Chicago 59
Munich 57
Hong Kong 56
Lauterbourg 50
Hefei 46
The Dalles 46
Milan 43
Jakarta 41
Frankfurt am Main 38
São Paulo 37
Tokyo 36
Helsinki 35
San Mateo 32
Boston 31
St Louis 30
Ann Arbor 29
Wilmington 28
Bremen 26
Buffalo 26
Princeton 26
Boardman 25
Fairfield 24
Turku 23
Haiphong 20
Marseille 19
Paris 19
London 18
Nuremberg 17
Santa Clara 17
Seoul 17
Jacksonville 16
Orem 15
Salt Lake City 15
Warsaw 15
Brussels 14
Kent 14
Lappeenranta 14
Moscow 14
Nanjing 14
Abidjan 13
Da Nang 13
Seattle 13
Tukwila 13
Dallas 12
Phoenix 12
Rio de Janeiro 12
Toronto 11
Chennai 10
Izmir 10
Lancaster 10
Montreal 10
North Bergen 10
Tampa 10
Brooklyn 9
Cattolica 9
Denver 9
Düsseldorf 9
Houston 9
Johannesburg 9
Vienna 9
Augusta 8
Elk Grove Village 8
Florence 8
Manchester 8
Porto Alegre 8
Stockholm 8
Mexico City 7
Naples 7
San Francisco 7
Shenzhen 7
Amman 6
Amsterdam 6
Andover 6
Atlanta 6
Belo Horizonte 6
Biên Hòa 6
Bogotá 6
Can Tho 6
Dearborn 6
Dhaka 6
Guayaquil 6
Hải Dương 6
Kunming 6
Portsmouth 6
San Diego 6
Tashkent 6
Tianjin 6
Totale 3.516
Salva come PNG Salva come JPEG
Nome #
Neoadjuvant chemotherapy in breast cancer: An advanced personalized multidisciplinary prehabilitation model (apmp-m) to optimize outcomes 332
Multiple Bayesian network meta-analyses to establish therapeutic algorithms for metastatic triple negative breast cancer 212
BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study 211
Development of a digital research assistant for the management of patients’ enrollment in oncology clinical trials within a research hospital 198
Level II Oncoplastic Surgery as an Alternative Option to Mastectomy with Immediate Breast Reconstruction in the Neoadjuvant Setting: A Multidisciplinary Single Center Experience 166
Development of a digital research assistant for the management of patients’ enrollment in oncology clinical trials within a research hospital 160
Impact of bevacizumab containing first line chemotherapy on recurrent disease in epithelial ovarian cancer: A case-control study 156
BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-Making 155
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence 155
Ovarian reserve after chemotherapy in breast cancer: A systematic review and meta-analysis 155
Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: a pilot study 154
Techniques for sentinel node biopsy in breast cancer 153
Prospective Study Investigating the Efficacy and Safety of a Scalp Cooling Device for the Prevention of Alopecia in Women Undergoing (Neo)Adjuvant Chemotherapy for Breast Cancer 151
Breast cancer drug approvals issued by EMA: A review of clinical trials 146
Palbociclib plus fulvestrant or everolimus plus exemestane for pretreated advanced breast cancer with lobular histotype in er+/her2− patients: A propensity score-matched analysis of a multicenter retrospective patient series 145
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial 143
An Innovative Scoring System to Select the Optimal Surgery in Breast Cancer after Neoadjuvant Chemotherapy 141
Accessible model predicts response in hormone receptor positive HER2 negative breast cancer receiving neoadjuvant chemotherapy 138
Real-world management of trabectedin/pegylated liposomal doxorubicin in platinum-sensitive recurrent ovarian cancer patients: A national survey 137
Pregnancy-Associated Breast Cancer: A Multidisciplinary Approach 137
Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy 135
Oligometastatic Breast Cancer: How to Manage It? 130
Multigenic panels in breast cancer: Clinical utility and management of patients with pathogenic variants other than BRCA1/2 127
Palliative electrochemotherapy in primary or recurrent vulvar cancer 127
Conservative Surgery in cT4 Breast Cancer: Single-Center Experience in the Neoadjuvant Setting 126
Role of radiomics in predicting early disease recurrence in locally advanced breast cancer patients: integration of radiomic features and RECIST criteria 122
Cdk4/6 inhibitor treatments in patients with hormone receptor positive, her2 negative advanced breast cancer: Potential molecular mechanisms, clinical implications and future perspectives 120
Identification of twenty-nine novel germline unclassified variants of BRCA1 and BRCA2 genes in 1400 Italian individuals 116
Malignant Mesenchymal Tumors of the Breast: Current Challenges and New Perspectives on Primary Sarcomas and Malignant Phyllodes Tumors 115
PI3K Inhibitors in Advanced Breast Cancer: The Past, The Present, New Challenges and Future Perspectives 114
Baseline 18F-FDG PET/CT for predicting pathological response to neoadjuvant chemotherapy and prognosis in locally advanced breast cancer patients: analysis of tumor and lymphoid organs metabolic parameters 114
Anthracyclines strike back: Rediscovering non‐pegylated liposomal doxorubicin in current therapeutic scenarios of breast cancer 112
Upfront HIPEC and bevacizumab-containing adjuvant chemotherapy in advanced epithelial ovarian cancer 112
Overall survival of CDK4/6-inhibitors-based treatments in clinically relevant subgroups of metastatic breast cancer: systematic review and meta-analysis 111
Characterization of a new BRCA1 rearrangement in an Italian woman with hereditary breast and ovarian cancer syndrome 110
Updated Neoadjuvant Treatment Landscape for Early Triple Negative Breast Cancer: Immunotherapy, Potential Predictive Biomarkers, and Novel Agents 106
Pregnancy-Associated Breast Cancer: A Multidisciplinary Approach 106
Germline BRCA 1-2 status prediction through ovarian ultrasound images radiogenomics: a hypothesis generating study (PROBE study) 102
Spectrum of germline BRCA1 and BRCA2 variants identified in 2351 ovarian and breast cancer patients referring to a reference cancer hospital of Rome 102
Impact of scalp cooling device (SCD) in preventing alopecia in women undergoing chemotherapy for breast cancer 99
Neoadjuvant Chemotherapy in Breast Cancer: An Advanced Personalized Multidisciplinary Prehabilitation Model (APMP-M) to Optimize Outcomes 98
Neoadjuvant Chemotherapy Followed by Maintenance Therapy With or Without Bevacizumab in Unresectable High-Grade Serous Ovarian Cancer: A Case-Control Study 96
Level II Oncoplastic Surgery as an Alternative Option to Mastectomy with Immediate Breast Reconstruction in the Neoadjuvant Setting: A Multidisciplinary Single Center Experience 96
Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY study 76
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting 75
Assessing the pathogenicity of BRCA1/2 variants of unknown significance: Relevance and challenges for breast cancer precision medicine 74
Neoadjuvant therapy for triple-negative breast cancer: potential predictive biomarkers of activity and efficacy of platinum chemotherapy, PARP- and immune-checkpoint-inhibitors 61
Lifestyle and environmental factors in women carrying BRCA pathogenic variants with and without cancer 38
Endocrine toxicities in immune checkpoint inhibitors and tyrosine kinase inhibitors combined treatment: from clinical trials to real-life practice 11
The Gut Microbiota in Perimenopausal Anxiety: A Novel Therapeutic Pathway Through Diet 8
Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer 6
Activity and Efficacy of Neoadjuvant Chemotherapy in Luminal-HER2 Negative Early Breast Cancer According to HER2 Score (Low vs. Score 0): A Retrospective Study 4
The role of body composition in neurological and hematologic toxicity in a retrospective analysis of 120 breast cancer patients undergoing neoadjuvant chemotherapy: the COMBOTOX study 3
Primary adrenal insufficiency induced by immune checkpoint inhibitors (ICIs): a case series and systematic literature review 3
Real life outcome analysis of breast cancer brain metastases treated with Trastuzumab Deruxtecan 3
Modern Personalized Strategies for Breast Cancer Treatment: Bridging Precision Oncology and Psycho-Oncology 2
Pregnancy vs. Postpartum Breast Cancer: Distinct Tumor Biology and Survival Trends in a Contemporary Cohort 2
Predictive risk factors of recurrence in breast cancer after neoadjuvant treatment: the NEORISK study 2
Prediction of germline BRCA 1/2 genes pathogenetic variants from ultrasound images of healthy ovaries: Radiogenomics as an innovative tool to prevent BRCA-related cancers (PROBE II) 1
Totale 6.310
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.921
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.921
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217 0 0 0 0 0 0 0 0 0 0 0 7
2021/2022368 24 17 10 27 11 28 15 51 18 21 78 68
2022/2023761 93 102 66 126 29 100 46 57 94 14 17 17
2023/2024463 15 92 19 29 22 75 52 24 12 22 44 57
2024/20251.325 22 19 105 39 94 52 40 49 130 196 377 202
2025/20263.156 371 98 187 367 497 151 606 165 227 222 164 101
Totale 6.310